MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carr, B. A.
Right arrow Articles by Yost, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carr, B. A.
Right arrow Articles by Yost, G. S.

Vol. 63, Issue 5, 1137-1147, May 2003

Characterization of Pulmonary CYP4B2, Specific Catalyst of Methyl Oxidation of 3-Methylindole

Brian A. Carr, Swayampakula Ramakanth,1 Ghazi A. Dannan,2 and Garold S. Yost

Department of Pharmacology and Toxicology, University of Utah Salt Lake City, Utah

The selective toxicity of chemicals to lung tissues is predominately mediated by the selective expression of certain pulmonary cytochrome P450 enzymes. This report describes the purification, cloning, and characterization of a unique enzyme, CYP4B2, from goat lung. The purified P450 enzyme was isolated by multistep ion exchange chromatography to electrophoretic homogeneity with an apparent molecular mass of 55,000 Da. Western blotting studies demonstrated that CYP4B enzymes were selectively expressed in lung tissues of rabbits, rats, and mice. Two cDNAs, CYP4B2 and CYP4B2v, were cloned from goat lung tissue. CYP4B2 was predicted to be 511 amino acids and approximately 82% similar to the four known CYP4B1 proteins. Concurrently, a variant of the known human CYP4B1 cDNA, that contained a S207 insertion, was cloned from human lung tissue. The modified recombinant goat CYP4B2 was expressed in Escherichia coli and the enzyme catalyzed the N-hydroxylation of the prototypical substrate 2AF. CYP4B2 preferentially dehydrogenated, rather than hydroxylated, the pneumotoxicant 3-methylindole (3MI) (Vmax = 4.61 versus 0.83 nmol/nmol of P450/min, respectively). To investigate the relevance of covalent heme binding of CYP4 enzymes in CYP4B2-mediated metabolism of 3MI, a site-directed mutant (CYP4B2/A315E) was evaluated. The mutation had little effect on the Vmax of either dehydrogenation or hydroxylation but increased the Km, which decreased the catalytic efficiency (V/K) for 3MI. The A315E mutation shifted the absorbance maximum of the enzyme from 448 to 451 nm, suggesting that the electron density of the heme was altered. These results demonstrate that CYP4B2 is highly specific for methyl group oxidation of 3MI, without formation of ring-oxidized metabolites, and seems to be predominately responsible for the highly organ-specific toxicity of 3MI in goats.


1 Present address: Regeneron Pharmaceuticals, 777 Old Sawmill River Road, Tarrytown, NY 10591.

2 Present address: USEPA, Office of Pesticides Programs, 7509C, 401 M Street, S.W., Washington, DC 20460.


Copyright © 2003 by U.S. Government



This article has been cited by other articles:


Home page
Toxicol SciHome page
J. M. Weems, Ned. S. Cutler, C. Moore, W. K. Nichols, D. Martin, E. Makin, J. G. Lamb, and G. S. Yost
3-Methylindole is Mutagenic and a Possible Pulmonary Carcinogen
Toxicol. Sci., November 1, 2009; 112(1): 59 - 67.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Chen, R.-A. Cue, K. Lundstrom, J. D. Wood, and O. Doran
Regulation of CYP2A6 Protein Expression by Skatole, Indole, and Testicular Steroids in Primary Cultured Pig Hepatocytes
Drug Metab. Dispos., January 1, 2008; 36(1): 56 - 60.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
X. Zhang, Q.-Y. Zhang, D. Liu, T. Su, Y. Weng, G. Ling, Y. Chen, J. Gu, B. Schilling, and X. Ding
EXPRESSION OF CYTOCHROME P450 AND OTHER BIOTRANSFORMATION GENES IN FETAL AND ADULT HUMAN NASAL MUCOSA
Drug Metab. Dispos., October 1, 2005; 33(10): 1423 - 1428.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics